Brown Brothers Harriman & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.64M | Sell |
97,895
-533
| -0.5% | -$30.6K | 0.02% | 210 |
|
|
2026
Q1 | $5.97M | Buy |
98,428
+13,926
| +16% | +$812K | 0.03% | 184 |
|
|
2025
Q4 | $4.56M | Buy |
84,502
+7,223
| +9% | +$347K | 0.02% | 181 |
|
|
2025
Q3 | $3.49M | Sell |
77,279
-408
| -0.5% | -$19.1K | 0.02% | 195 |
|
|
2025
Q2 | $3.6M | Buy |
77,687
+4,881
| +7% | +$240K | 0.02% | 188 |
|
|
2025
Q1 | $4.44M | Sell |
72,806
-8,026
| -10% | -$468K | 0.03% | 160 |
|
|
2024
Q4 | $4.57M | Sell |
80,832
-5,597
| -6% | -$313K | 0.03% | 160 |
|
|
2024
Q3 | $4.47M | Sell |
86,429
-7,111
| -8% | -$334K | 0.03% | 161 |
|
|
2024
Q2 | $3.88M | Sell |
93,540
-2,011
| -2% | -$90K | 0.03% | 157 |
|
|
2024
Q1 | $5.18M | Sell |
95,551
-2,299
| -2% | -$117K | 0.04% | 137 |
|
|
2023
Q4 | $5.02M | Sell |
97,850
-2,267
| -2% | -$119K | 0.04% | 139 |
|
|
2023
Q3 | $5.81M | Sell |
100,117
-1,426
| -1% | -$87.4K | 0.05% | 128 |
|
|
2023
Q2 | $6.49M | Sell |
101,543
-10,966
| -10% | -$735K | 0.05% | 114 |
|
|
2023
Q1 | $7.8M | Sell |
112,509
-3,836
| -3% | -$271K | 0.07% | 89 |
|
|
2022
Q4 | $8.37M | Buy |
116,345
+23,525
| +25% | +$1.77M | 0.07% | 87 |
|
|
2022
Q3 | $6.6M | Buy |
92,820
+4,209
| +5% | +$305K | 0.06% | 93 |
|
|
2022
Q2 | $6.82M | Sell |
88,611
-371
| -0.4% | -$28.3K | 0.06% | 96 |
|
|
2022
Q1 | $6.5M | Sell |
88,982
-1,774
| -2% | -$119K | 0.05% | 103 |
|
|
2021
Q4 | $5.66M | Sell |
90,756
-15,304
| -14% | -$898K | 0.03% | 114 |
|
|
2021
Q3 | $6.28M | Sell |
106,060
-11,268
| -10% | -$742K | 0.04% | 104 |
|
|
2021
Q2 | $7.84M | Buy |
117,328
+269
| +0.2% | +$17.5K | 0.05% | 98 |
|
|
2021
Q1 | $7.39M | Buy |
117,059
+1,361
| +1% | +$84.7K | 0.05% | 97 |
|
|
2020
Q4 | $7.18M | Buy |
115,698
+2,977
| +3% | +$183K | 0.05% | 92 |
|
|
2020
Q3 | $6.8M | Sell |
112,721
-2,292
| -2% | -$138K | 0.05% | 85 |
|
|
2020
Q2 | $6.76M | Sell |
115,013
-8,136
| -7% | -$487K | 0.05% | 88 |
|
|
2020
Q1 | $6.86M | Buy |
123,149
+9,154
| +8% | +$560K | 0.06% | 85 |
|
|
2019
Q4 | $7.32M | Buy |
113,995
+11,863
| +12% | +$679K | 0.05% | 96 |
|
|
2019
Q3 | $5.18M | Buy |
102,132
+6,618
| +7% | +$311K | 0.03% | 108 |
|
|
2019
Q2 | $4.33M | Sell |
95,514
-1,553
| -2% | -$72.3K | 0.03% | 112 |
|
|
2019
Q1 | $4.63M | Sell |
97,067
-857
| -0.9% | -$42.7K | 0.03% | 109 |
|
|
2018
Q4 | $5.09M | Buy |
97,924
+15,952
| +19% | +$857K | 0.04% | 100 |
|
|
2018
Q3 | $5.09M | Buy |
81,972
+3,568
| +5% | +$212K | 0.03% | 102 |
|
|
2018
Q2 | $4.34M | Sell |
78,404
-12,471
| -14% | -$674K | 0.03% | 104 |
|
|
2018
Q1 | $5.75M | Sell |
90,875
-87
| -0.1% | -$5.6K | 0.03% | 93 |
|
|
2017
Q4 | $5.57M | Buy |
90,962
+880
| +1% | +$55K | 0.03% | 93 |
|
|
2017
Q3 | $5.74M | Sell |
90,082
-3,813
| -4% | -$223K | 0.03% | 86 |
|
|
2017
Q2 | $5.23M | Sell |
93,895
-422
| -0.4% | -$23K | 0.03% | 85 |
|
|
2017
Q1 | $5.13M | Sell |
94,317
-3,718
| -4% | -$204K | 0.03% | 89 |
|
|
2016
Q4 | $5.73M | Buy |
98,035
+76
| +0.1% | +$4.16K | 0.03% | 88 |
|
|
2016
Q3 | $5.28M | Sell |
97,959
-1,376
| -1% | -$88.4K | 0.03% | 88 |
|
|
2016
Q2 | $7.31M | Sell |
99,335
-8,529
| -8% | -$603K | 0.04% | 83 |
|
|
2016
Q1 | $6.89M | Sell |
107,864
-2,147
| -2% | -$135K | 0.04% | 83 |
|
|
2015
Q4 | $7.57M | Sell |
110,011
-494
| -0.4% | -$32.6K | 0.04% | 84 |
|
|
2015
Q3 | $6.54M | Sell |
110,505
-1,532
| -1% | -$97.2K | 0.03% | 92 |
|
|
2015
Q2 | $7.46M | Sell |
112,037
-1,050
| -0.9% | -$69.2K | 0.03% | 84 |
|
|
2015
Q1 | $7.29M | Sell |
113,087
-1,112
| -1% | -$69.6K | 0.03% | 86 |
|
|
2014
Q4 | $6.74M | Sell |
114,199
-3,873
| -3% | -$218K | 0.03% | 96 |
|
|
2014
Q3 | $6.04M | Buy |
118,072
+532
| +0.5% | +$26.6K | 0.02% | 102 |
|
|
2014
Q2 | $5.7M | Sell |
117,540
-7,578
| -6% | -$373K | 0.02% | 107 |
|
|
2014
Q1 | $6.5M | Sell |
125,118
-118,772
| -49% | -$6.32M | 0.03% | 95 |
|
|
2013
Q4 | $13M | Buy |
243,890
+111,393
| +84% | +$5.67M | 0.03% | 91 |
|
|
2013
Q3 | $6.13M | Sell |
132,497
-58,273
| -31% | -$2.56M | 0.03% | 92 |
|
|
2013
Q2 | $8.53M | Buy |
+190,770
| New | +$8.28M | 0.04% | 80 |
|
Other funds holding BMY
Brown Brothers Harriman & Co's BMY Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its Bristol-Myers Squibb (BMY) stake by 0.54% in Q2 2026, selling an estimated $30.6K and leaving 97,895 shares worth $5.64M. The position accounts for 0.02% of the portfolio, ranked #210.
Brown Brothers Harriman & Co first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $13M in Q4 2013. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Brown Brothers Harriman & Co held 97,895 shares of Bristol-Myers Squibb worth $5.64M as of Q2 2026.
- Brown Brothers Harriman & Co sold 533 Bristol-Myers Squibb shares in Q2 2026, an estimated $30.6K.
- Bristol-Myers Squibb made up 0.02% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #210 holding.
- Brown Brothers Harriman & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Brown Brothers Harriman & Co's Bristol-Myers Squibb position peaked at $13M in Q4 2013.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.